GHRP-2 vs GHRP-6: Side Effects, Hunger, and Which to Choose

GHRP-2 and GHRP-6 are the original ghrelin mimetics — synthetic hexapeptides designed to stimulate GH release by activating the growth hormone secretagogue receptor (GHSR-1a). Both predate Ipamorelin by nearly a decade, and both are still in use despite Ipamorelin largely replacing them in modern protocols. If you've used GHRP-2 or GHRP-6 — or are deciding between them — the comparison is worth understanding precisely, because the differences aren't minor.

The short version: GHRP-6 drives a stronger appetite response due to its more promiscuous ghrelin activity, while GHRP-2 delivers a cleaner pulse with less hunger but a modestly greater cortisol elevation at higher doses. Neither is clearly superior; the better choice depends on your goals, your eating patterns, and how you respond to cortisol side effects.

What both peptides are doing

GHRP-2 and GHRP-6 are both hexapeptides that bind to the GHSR-1a receptor — the same receptor that the endogenous peptide ghrelin activates. When this receptor is stimulated, the pituitary releases GH in a pulsatile burst. The magnitude of that burst can be substantially amplified by combining a GHRP with a GHRH analog like CJC-1295 (no-DAC) or Sermorelin; the two signals hit the pituitary through different receptor pathways and the GH release is synergistic rather than additive.

Both peptides have a short half-life — roughly 15 to 60 minutes — and are typically dosed subcutaneously or intramuscularly in the 100–300 mcg range. The GH pulse peaks 15–30 minutes post-injection and returns to baseline within 2–3 hours.

What separates them is what else happens when the GHSR-1a is activated beyond the pituitary.

The hunger difference

The most practically significant difference between GHRP-2 and GHRP-6 is appetite.

Ghrelin is sometimes called the "hunger hormone" because activating the GHSR-1a receptor in the gut and hypothalamus produces a powerful appetite signal. GHRP-6 is a near-full ghrelin mimetic in this regard. Most users report a significant and often uncomfortable hunger response 20–45 minutes after injecting GHRP-6 — a sudden, intense need to eat regardless of recent meal timing. For people running a lean-bulk or who inject fasted (which tends to maximize GH release), this can be useful. For people trying to cut or maintain, it's a problem.

GHRP-2 binds the same receptor but with somewhat less ghrelin-mimetic activity in peripheral tissue. The hunger effect is real but substantially blunted. Most GHRP-2 users describe mild appetite stimulation rather than the driven hunger that GHRP-6 causes. It's not zero — fasted injections will still make you want to eat — but it's manageable in a way that GHRP-6 hunger often isn't.

If appetite management matters to you — because you're dieting, have a sensitive stomach, or inject multiple times daily — GHRP-2 is the cleaner option on this front.

Cortisol and prolactin

Both peptides elevate cortisol and prolactin above baseline. This is a well-documented side effect of ghrelin-receptor agonism, and it's part of why Ipamorelin was developed to fill the same GH-stimulating niche without these hormonal consequences.

The relative magnitude differs slightly:

GHRP-2 at higher doses (200–300 mcg) tends to produce a more pronounced cortisol spike than GHRP-6 at the same dose. This isn't catastrophic for most users, but chronic cortisol elevation — particularly if you're injecting two or three times daily — can impair recovery, disrupt sleep, and partly offset the anabolic benefits of the GH pulse. People who inject GHRP-2 and notice increased anxiety, poor sleep quality, or feeling "wired" post-injection are often seeing this effect.

Prolactin elevation is mild with both compounds at typical doses and rarely clinically significant, but it's worth tracking if you run either compound for extended cycles.

GH pulse quality

In terms of raw GH pulse magnitude, GHRP-2 generally edges out GHRP-6. Studies in healthy adults using standardized doses have shown GHRP-2 produces a somewhat higher GH peak. Whether this difference translates into meaningfully different anabolic or recovery outcomes at the doses most users run (100–200 mcg) is unclear — the signal difference is real but probably smaller than the variability in individual GHRP response.

More practically: both compounds produce their best GH output when the pituitary is not already saturated with somatostatin. Injecting in a true fasted state, away from carbohydrate and fat intake, and timing shots at least 3 hours after a prior injection gives you the best pulse. This is true of both GHRP-2 and GHRP-6 equally.

Stacking with a GHRH

Neither GHRP-2 nor GHRP-6 should be thought of in isolation if you're trying to maximize GH release. Both produce a substantially larger GH pulse when co-administered with a GHRH peptide. The combination of a GHRP + GHRH amplifies GH output non-linearly — studies show the combination produces roughly 5–10x more GH than either alone.

For most people, the practical stack is GHRP-2 or GHRP-6 (100–150 mcg) + CJC-1295 no-DAC or Sermorelin (100–150 mcg) per injection. See our GH secretagogues guide for the full context on pairing these compounds.

Practical protocol patterns

The community has converged on a few common patterns:

For lean bulking or off-season recovery: GHRP-6 can be a useful ally because the appetite stimulus works in your favor — you're trying to eat more anyway, and the GH pulse on top of increased food intake promotes lean-mass accrual. Two injections daily (morning fasted + pre-bed) are common.

For cutting or maintenance: GHRP-2 is the better choice because you're not fighting appetite side effects on top of a deficit. The modestly higher cortisol is a trade-off worth knowing about; keeping doses at 100–150 mcg rather than 200–300 mcg tends to minimize it.

For sleep-focused protocols: Pre-bed dosing of either compound in the fasted state can augment the GH pulse that naturally occurs during deep sleep. GHRP-6's hunger effect at 10 p.m. is annoying; GHRP-2 is somewhat easier to manage here.

Why many people have moved to Ipamorelin

Both GHRP-2 and GHRP-6 are older compounds with established profiles, but Ipamorelin is now the dominant first-line GHRP for most users — and for a reason. Ipamorelin produces a GH pulse comparable in magnitude to GHRP-2 or GHRP-6 without meaningful cortisol or prolactin elevation, and with minimal hunger response. It's effectively a refined version that removed the side effects that made the older compounds less than ideal.

The cases for still using GHRP-2 or GHRP-6:

• Cost (they're often cheaper per mcg)
• GHRP-6 specifically when appetite stimulation is desired
• When Ipamorelin supply is a problem

For most new users, Ipamorelin is a better starting point. GHRP-2 and GHRP-6 are more appropriate for users who've already explored the space and have specific reasons to choose them.

Desensitization and cycling

Both GHRP-2 and GHRP-6 cause some receptor downregulation with sustained daily use. Continuous daily dosing for weeks at high frequency (three or more injections per day) leads to progressively blunted GH response — the receptor doesn't fully reset between pulses. Running 2 injections per day rather than 3, or cycling with 4–8 weeks on and a break, helps maintain responsiveness.

This desensitization pattern is different from Hexarelin, which desensitizes more aggressively. See why Hexarelin desensitizes faster than other GHRPs for a detailed comparison of that mechanism.

The decision framework

If you're trying to choose between GHRP-2 and GHRP-6:

1. Hunger tolerable or desirable? → GHRP-6. Hunger is a problem? → GHRP-2.
2. Primary goal is body composition / cutting? → GHRP-2 (less appetite disruption, lower dose cortisol profile at 100–150 mcg is manageable).
3. Primary goal is off-season mass gain? → GHRP-6 (appetite assist can help hit caloric targets).
4. Running multiple daily injections long-term? → Consider Ipamorelin instead of either.
5. Stacking with a GHRH? → Yes, for both compounds; it's the highest-leverage change you can make to GH output.

Neither compound is clearly dominant. They occupy slightly different niches within the same mechanism, and both have been effectively replaced in most protocols by Ipamorelin without major loss of efficacy. If you're starting fresh, Ipamorelin is the better entry point; if you have specific reasons to use the older compounds, this comparison should help you pick the right one.

Related reading

• GH Secretagogues: The Complete Guide
• Side Effects Overview